{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/295189988"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "01 MAR 2013: Wright Medical Group acquired BioMimetic Therapeutics for $380m or $12.97 per share, based on Wright???s closing stock price on 16 NOV 2012.BioMimetic Therapeutics (BMTI) was a Tennessee based biotechnology company focused on development & marketing of clinically proven products to promote the healing of musculoskeletal injuries & diseases, including therapies for orthopaedic & sports" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "evaluategroup.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/227717480"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/295189988"] } } }
